🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to assess if eslicarbazepine acetate (ESL) treatment (start...
Status
Completed
Location
Klinikum am Wörthersee, Abteilung fur Neurologie
Start Date
2019-05-29
Trial ID
NCT06597084
Treatments Being Tested
This was a multinational, randomised, double-blind, placebo-controlled, par...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT01820559
Treatments Being Tested
Phase I, two-centre, open-label, randomized, gender-balanced, single-dose, ...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT02284880
The primary objective of the study is to evaluate the efficacy of eslicarba...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2004-07
Trial ID
NCT00957047
Treatments Being Tested
Single-blind, single-centre, fixed-order study to evaluate the PD effects o...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT02284828
Treatments Being Tested
The primary objective of the study is to assess the efficacy of eslicarbaze...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00981227
Treatments Being Tested
The primary objective was to evaluate the efficacy of eslicarbazepine aceta...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2004-12
Trial ID
NCT00957372
Treatments Being Tested
Single centre, open-label, randomised, three-way crossover study in 18 heal...
Status
Completed
Location
CEB - Centre for Bioavailability Studies, AIBILI
Start Date
2004-02
Trial ID
NCT02279667
Single-centre, open-label, randomised, gender-balanced, 3-way crossover, 3-...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT02288312
Treatments Being Tested
Multicentre, double-blind, randomised, parallel-group, placebo-controlled d...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT01822678
Treatments Being Tested